National Academies Press: OpenBook

Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda (1993)

Chapter: Appendix A: Agenda fr the IOM Workshop 'Antiprogestins: Assessing the Science'

« Previous: Animals as Models for Studying Antiprogestins
Suggested Citation:"Appendix A: Agenda fr the IOM Workshop 'Antiprogestins: Assessing the Science'." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
×

APPENDIXES

Suggested Citation:"Appendix A: Agenda fr the IOM Workshop 'Antiprogestins: Assessing the Science'." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
×
This page in the original is blank.
Suggested Citation:"Appendix A: Agenda fr the IOM Workshop 'Antiprogestins: Assessing the Science'." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
×

A
Agenda for the IOM Workshop ''Antiprogestins: Assessing the Science," April 13–14, 1993

APRIL 13

Room 104 Green Building 2001 Wisconsin Avenue, N.W. Washington, D.C.

8:00–8:30

Continental Breakfast, Room 110

8:30–8:45

Welcome to Participants

8:45–9:00

Purpose of the Workshop

 

Leslie Z. Benet, Ph.D., Chairman

Committee on Antiprogestins: Assessing the Science

9:00–10:30

SESSION I. Overview and Background: Background, Development, Mechanism of Action

9:00–9:30

Development and Future Directions in the

Development of Steroid Antagonists

Étienne-Émile Baulieu, M.D., Ph.D.

Professor of Biochemistry

School of Medicine

University of Paris-Sud

Director of Research, INSERM

9:30–10:00

Antiprogestational/Antiglucocorticoid Compounds:

Structure-Function Relationships

Nancy L. Weigel, Ph.D.

Research Associate Professor

Department of Cell Biology

Baylor School of Medicine

Suggested Citation:"Appendix A: Agenda fr the IOM Workshop 'Antiprogestins: Assessing the Science'." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
×

10:00–10:30

Discussion of Session I

10:30–10:45

BREAK

10:45–2:15

SESSION II. State of the Science and Research Directions—Uses of Antiprogestins: The Reproductive Cycle

10:45–11:00

Introduction

Lynnette K. Nieman, M.D.

Senior Investigator, Deputy Clinical Director,

Special Assistant to the Scientific Director

National Institute of Child Health and Development

National Institutes of Health

11:00–11:30

Daily or Luteal Phase Administration: Mechanism of Action of the Antigestagens on the Endometrium

David T. Baird, M.D.

MRC Clinical Research Professor of Reproductive

Endocrinology

Center for Reproductive Biology

Department of Obstetrics and Gynecology

The University of Edinburgh

11:30–12:00

Uses of Antiprogestins Before 63 Days

Marc Bygdeman, M.D.

Chairman

Department of Obstetrics and Gynecology

Karolinska Institute

Stockholm

12:00–12:15

Uses of Antiprogestins After 63 Days

André Ulmann, M.D., Ph.D.

Direction; Domaine Thérapeutique Endocrinologie

Roussel-Uclaf

Romainville, France

12:15–1:30

LUNCH

1:30–1:45

Comments on Session II

David Grimes, M.D.

Professor and Vice Chair

Department of Obstetrics/Gynecology and Reproductive

Sciences

University of California at San Francisco

Suggested Citation:"Appendix A: Agenda fr the IOM Workshop 'Antiprogestins: Assessing the Science'." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
×

1:45–2:15

Discussion of Session II

2:15–2:30

BREAK

2:30–4:20

SESSION III. State of the Science and Research Directions: Therapeutic Uses of Antiprogestins

2:30–3:00

Use of Antiprogestin in the Management of Endometriosis and Leiomyoma

Samuel S.C. Yen, M.D.

Professor and W.R. Persons Chair

Department of Reproductive Medicine

University of California at San Diego

3:00–3:30

Use of Antiprogestin in the Treatment of Breast Cancer

Kathryn B. Horwitz, Ph.D.

Departments of Medicine and Pathology

Division of Endocrinology

University of Colorado Health Sciences Center

3:30–3:50

Animal Models and Studies on the Mode of Action of Antiprogestins in Growth Inhibition of Mammary Tumors

David Henderson, Ph.D.

Head, Experimental Oncology

Schering AG, Berlin

3:50–4:20

Discussion of Session III

4:20–4:50

General Discussion

4:50 p.m.

Adjourn for the Day

APRIL 14

 

8:30–9:00

CONTINENTAL BREAKFAST (Room 110)

9:00–10:15

SESSION IV. State of the Science and Research Directions: Therapeutic Uses of Antiglucocorticoids

9:00–9:45

Lynnette K. Nieman, M.D.

Senior Investigator, Deputy Clinical Director,

Special Assistant to the Scientific Director

National Institute of Child Health and Development

National Institutes of Health

Suggested Citation:"Appendix A: Agenda fr the IOM Workshop 'Antiprogestins: Assessing the Science'." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
×

9:45–10:15

Discussion of Session IV

10:15–10:30

BREAK

10:30–10:50

SESSION V. Primate Models for the Study of Antiprogestins in Reproductive Medicine

 

Gary D. Hodgen, Ph.D.

The Howard and Georgeanna Jones Professor of

Reproductive Medicine

President, The Jones Institute Foundation

Eastern Virginia Medical School

10:50–11:00

Discussion of Session V

11:00–11:20

SUMMING UP

 

Paul F.A. Van Look, M.D., Ph.D.

Acting Director Special Programme of Research, Development

and Research Training in Human Reproduction

World Health Organization, Geneva

11:20–11:45

Late-Breaking Research Issues and Final Comments

11:45

ADJOURN WORKSHOP

Suggested Citation:"Appendix A: Agenda fr the IOM Workshop 'Antiprogestins: Assessing the Science'." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
×
Page 63
Suggested Citation:"Appendix A: Agenda fr the IOM Workshop 'Antiprogestins: Assessing the Science'." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
×
Page 64
Suggested Citation:"Appendix A: Agenda fr the IOM Workshop 'Antiprogestins: Assessing the Science'." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
×
Page 65
Suggested Citation:"Appendix A: Agenda fr the IOM Workshop 'Antiprogestins: Assessing the Science'." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
×
Page 66
Suggested Citation:"Appendix A: Agenda fr the IOM Workshop 'Antiprogestins: Assessing the Science'." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
×
Page 67
Suggested Citation:"Appendix A: Agenda fr the IOM Workshop 'Antiprogestins: Assessing the Science'." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press. doi: 10.17226/2203.
×
Page 68
Next: Appendix B: Background Papers and Presentations (In Order of Presentation at IOM Workshop) »
Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda Get This Book
×
 Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda
Buy Paperback | $50.00
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Mifepristone (RU486), the first clinically available antiprogestin, has generated great interest since its discovery in the early 1980s. Today, it is recognized that mifepristone, along with other antiprogestins, has a potentially significant therapeutic role in human health and disease, with likely applicability to a variety of pregnancy-related conditions (e.g., management of labor) and to contraception, endometriosis, and cancer, among others. But because mifepristone has been studied and used most widely as a means of nonsurgical abortion, political issues have thus far limited research on the drug and prevented its introduction into the U.S. market.

This book provides an unbiased evaluation of current knowledge about both the fundamental nature of antiprogestins as well as their possible use in treating numerous diseases and conditions, and it contains recommendations for future research.

READ FREE ONLINE

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!